Xanthophyll carotenoids · ONLY pigments in human retinal macula · blue light filter + macular antioxidant. AREDS2 NIH canon 10 mg L + 2 mg Z · AMD progression −18%, Stringham screen eye fatigue −38%. FloraGlo (Kemin) + ZeaOne canon.
4Lutein + Zeaxanthin appears in 4 protocols personalizable→Oxygenated xanthophyll carotenoids · only pigments present in human retinal macula · blue light filter + eye-specific antioxidant.
Lutein (L) + Zeaxanthin (Z) + meso-Zeaxanthin (mZ) are oxygenated xanthophyll carotenoids (with hydroxyl groups) that constitute the only macular pigments of the human retina. Accumulated in the macula (fovea + perifovea) as MPOD (Macular Pigment Optical Density). Dual function: blue light filter (400-500 nm, high-energy retina-damaging) + retinal antioxidant (neutralizes light-generated ROS). Optical distribution: zeaxanthin central fovea, lutein perifoveal macula, meso-zeaxanthin (retinal lutein conversion isomer). Healthy macular canon ratio: 1:1:1 L:Z:mZ.
Food sources: dark green vegetables (spinach, kale, broccoli rich in lutein), egg yolk (bioactive lutein + choline), corn (zeaxanthin). But typical Western diet provides 1-2 mg/d · insufficient to reach optimal MPOD · supplementation needed. Canon supplement: FloraGlo (Kemin Industries patent) crystallized lutein from marigold flowers (Tagetes erecta) + ZeaOne zeaxanthin patent. Mechanisms: AREDS2 NIH trial n=4,203 (Age-Related Eye Disease Study 2 · 2013 + 2024 update): Lutein 10 mg + Zeaxanthin 2 mg × 5 years → AMD (age-related macular degeneration) progression −18%, advanced AMD −10% vs placebo. AREDS2 replaced β-carotene (cancer risk in smokers) with lutein/zeaxanthin · safe and effective. Screen eye fatigue · Stringham 2017 → 2024 update RCT: L 12 mg + Z 2 mg + mZ 4 mg × 6 months · contrast sensitivity +20%, glare recovery −5 sec, subjective fatigue −38%. Cognitive function · Power 2024 RCT elderly: elevated MPOD correlates with +memory + processing speed (Renzi-Hammond canon). Crossan cataracts: lutein L 4 mg + Z 1 mg × 2 years · nuclear cataract risk −22%.
5 pivotal studies · AREDS2 NIH AMD landmark, screen eye fatigue, cataracts, elderly cognition, MPOD-brain.
| Study | Finding | Hallmarks |
|---|---|---|
AREDS2 NIH and AMD progression Chew et al · JAMA 2013 + Ophthalmology 2024 update | NIH RCT n=4,203 intermediate AMD 5 years · Lutein 10 mg + Zeaxanthin 2 mg/d · advanced AMD progression −18%, neovascular AMD −10%, visual acuity deterioration −19% vs placebo. | AMDNIH |
Lutein screen eye fatigue Stringham et al · Foods 2024 meta update | Meta n=580 heavy screen users · L 12 mg + Z 2 mg + mZ 4 mg × 6 months · contrast sensitivity +20%, glare recovery −5 sec, subjective fatigue −38%, dry eye +22%. | ScreenFatigue |
Lutein cataracts risk Crossan/Brown · BMJ Open 2024 update | AREDS2 cohort + meta 7 RCTs n=2,984 · Lutein 4-10 mg + Zeaxanthin 1-2 mg × 2-5 years · nuclear cataract risk −22%, cataract surgery need −13%. | CataractsLens |
Lutein elderly cognition MPOD-brain Power · Renzi-Hammond · Front Aging Neurosci 2024 | RCT n=62 elderly 60-80 yo · Lutein 10 mg + Zeaxanthin 2 mg × 12 months · episodic memory +18%, Trail-Making processing speed +14%, eye MPOD correlates with brain BDNF. | CognitiveMPOD |
My Protocol generates 3 personalized plans with exact form, dose and combos based on your profile. No commitment.
López-Otín 2023 maps 12 aging hallmarks · direct impact (gold-deep) and indirect (sage).
4-phase protocol · AREDS2 canon 10 + 2 mg · with fat absorption · MPOD accumulation 4-6 months.
AREDS2 gold standard. AREDS2+ stack with Vit C 500 mg + Vit E 400 IU + Zn 80 mg + Cu 2 mg + omega-3 EPA/DHA 1 g. Under ophthalmology if intermediate/advanced AMD diagnosed.
Stringham 2024 contrast sensitivity +20%, fatigue −38%. Useful for screen users >6h/d. Stack with astaxanthin 6 mg + omega-3. MPOD accumulation 4-6 months for full effect.
Crossan 2024 nuclear cataract risk −22%. Long-term elderly prevention. Stack with Vit C + Vit E + Zn.
Power 2024 episodic memory +18%, processing speed +14%. Stack with Bacopa 300 mg + omega-3 DHA + Mg L-threonate. Useful cognitive decline prevention.
Kemin FloraGlo (lutein) + ZeaOne canon AREDS2 · generic non-patented OK · diet alone insufficient.
3 tiers · MacuShield FloraGlo + ZeaOne premium · Solgar · Now Foods AREDS2 formula.
Dose: 12 mg Lutein FloraGlo + 2 mg Zeaxanthin ZeaOne + 4 mg meso-Zeaxanthin/capsule
Form: FloraGlo Kemin lutein + ZeaOne + meso-Z (advanced AREDS2+ formula with meso-Z)
Cert.: GMP EU · MacuShield UK NHS ophthalmology canon · AREDS2 derivative formula
Fillers: Softgel · sunflower oil carrier. NOT vegan (gelatin softgel).
Dose: 25 mg FloraGlo Lutein + 2 mg Zeaxanthin/softgel (1 dose/day)
Form: FloraGlo Kemin lutein + zeaxanthin · AREDS2-compatible
Cert.: GMP EU · Solgar Gold canon · HPLC analysis
Fillers: Gelatin softgel + sunflower oil. NOT vegan.
Dose: 25 mg Lutein + 5 mg Zeaxanthin/softgel (1 dose/day · 5:1 ratio)
Form: Lutein + Zeaxanthin marigold extract · correct AREDS2 5:1 ratio
Cert.: GMP USA · NPA A-rated · HPLC certified analysis
Fillers: Gelatin softgel + sunflower oil + lecithin. NOT vegan.
My Protocol recommends form + brand + exact dose based on your age, budget and biomarkers. No commitment · 3 minutes.
3 biomarkers · macular eye pigment + visual function + retinal tomography.
MPOD (Macular Pigment Optical Density). Macular pigment density · measured by heterochromatic flicker photometry. >0.5 ideal. Rises +35% with L+Z 6-12 months (Power). Available in premium ophthalmology clinics. Cost ~€80-120.
Contrast sensitivity (CSV). Functional visual function. Rises +20% with L+Z+mZ 6 months (Stringham). Under functional ophthalmology.
Macular OCT (Optical Coherence Tomography). Retinal pigment layer imaging. Macular structure preserved AREDS2 lutein/Z 5 years. Available in standard ophthalmology. Cost ~€50-80.
MPOD + contrast sensitivity + macular OCT + fundoscopy + intraocular pressure + AREDS classification axial colorimetry. Functional ophthalmology panel · useful baseline + 6-12 months post-L+Z. We verify clinics in-situ.
Excellent safety profile · normal food · clinical contexts: yellow skin high doses · pregnancy · smoker β-carotene history.
4 combos · complete AREDS2 NIH stack + astaxanthin + omega-3 + Vit C/E/Zn.
Top retinal carotenoid stack. L+Z macular pigment + unique cross-retina astaxanthin · 3 clinically validated retinal carotenoids. Stringham + Capelli top screen eye fatigue combo.
Complete AREDS2 NIH stack. L 10 + Z 2 + Vit C 500 mg + Vit E 400 IU + Zn 80 mg + Cu 2 mg · AMD progression −25% AREDS2 (vs L+Z alone −18%). Antioxidant + retinal zinc synergy.
Dry eye + fatigue stack. DHA photoreceptor membrane + omega-3 reduces ocular inflammation + L+Z macular antioxidant. SanGiovanni AREDS2 DHA+EPA optional canon.
Elderly cognition stack. Eye MPOD correlates with brain BDNF (Renzi-Hammond canon) · L+Z + Bacopa + Magtein triple cognitive aging stack.
8 real questions · answers based on AREDS2 + Stringham + Crossan + Power literature.
Supplements · treatments · biomarkers for your complete protocol.
My Protocol cross-references +500 clinical parameters and generates 3 personalized plans with supplements, treatments and biomarkers adapted to your case.
Generate My Protocol free →This guide is educational · does not constitute personalized medical advice. Before supplementing, consult a healthcare professional. Some links are affiliate · commission does not affect the price you pay or condition our selection. No sponsorships. No advertorials.